Literature DB >> 28558901

Associations of number and severity of depressive episodes with C-reactive protein and Interleukin-6.

Jitendra Jeenger1, Manu Sharma2, Devendra Mohan Mathur3.   

Abstract

BACKGROUND: Many researchers have found that the inflammatory process in the body and the brain may result in psychiatric disorders. Meta-analyses of cross-sectional studies have reported increase in inflammatory markers in depression. However, the direction of the association remains unclear. AIMS: To compare the levels of C-reactive protein (CRP) and Interleukin-6 (IL-6) in depressed and healthy controls. To study the associations of these biomarkers with severity and number of depressive episodes.
METHODS: A total of 72 subjects with major depression and 60 healthy controls were studied. CRP and IL-6 were measured in all subjects.
RESULTS: No significant differences were noted between depressed patients and healthy controls with regard to CRP (p=0.29) and IL-6 (p=0.50). Those who were suffering from severe depression based on Beck's Depressive Inventory (BDI), were positively correlated with raised CRP (p=0.011) in comparison to patients with mild to moderate depression. Single and recurrent depressive disorder (RDD) were not associated with significant rise in CRP (p=0.866) and IL-6 (p=0.531).
CONCLUSIONS: Severity of depression is correlated with elevated CRP but not with IL-6. No association found between number of depressive episodes and levels of CRP and IL-6. It is possible that immune dysregulation is not generally present in depression, but might be restricted to particular subgroups of depressed patients. Several factors that could influence the depression and inflammation relationship need further investigation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Depression; Inflammatory markers; Interleukin-6; Recurrent depressive disorder

Mesh:

Substances:

Year:  2017        PMID: 28558901     DOI: 10.1016/j.ajp.2017.02.016

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  4 in total

1.  Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice.

Authors:  Songnian Fu; Jiangtao Wang; Chenguang Hao; Haihong Dang; Sheng Jiang
Journal:  Psychopharmacology (Berl)       Date:  2019-03-07       Impact factor: 4.530

2.  PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

Authors:  Erica M Richards; Paolo Zanotti-Fregonara; Masahiro Fujita; Laura Newman; Cristan Farmer; Elizabeth D Ballard; Rodrigo Machado-Vieira; Peixiong Yuan; Mark J Niciu; Chul Hyoung Lyoo; Ioline D Henter; Giacomo Salvadore; Wayne C Drevets; Hartmuth Kolb; Robert B Innis; Carlos A Zarate
Journal:  EJNMMI Res       Date:  2018-07-03       Impact factor: 3.138

3.  C-reactive protein, brain-derived neurotrophic factor, interleukin-2, and stressful life events in drug-naive first-episode and recurrent depression: A cross-sectional study.

Authors:  Jitendra Jeenger; Vikas Singroha; Manu Sharma; Devendra Mohan Mathur
Journal:  Indian J Psychiatry       Date:  2018 Jul-Sep       Impact factor: 1.759

4.  S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.

Authors:  Hannah Maier; Saskia Helm; Sermin Toto; Nicole Moschny; Wolfgang Sperling; Thomas Hillemacher; Kai G Kahl; Ewgeni Jakubovski; Stefan Bleich; Helge Frieling; Alexandra Neyazi
Journal:  Dis Markers       Date:  2018-01-10       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.